PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

A federal lawsuit challenges New York’s Green Light Law, which has allowed thousands of nonresident immigrants to obtain ...

Arizona’s Family Investigates found providers high on the job, two of them prescribing hundreds of opioids. Most of them are ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals ...

Our recent study, published in the Journal of Health Politics, Policy and Law, tracks how the Trump administration applied public pressure on the FDA during the 2020 election season, sparking a ...

Further, designating our application for priority review reaffirms that the FDA views PDCD as a serious condition” The NDA is supported by results from a Phase 3 double-blind placebo-controlled ...

After years of warnings from health advocates about cancer and other issues associated with Red No. 3, the Food and Drug Administration has banned the dye, which is found in thousands of food and ...

This NDA acceptance represents a pivotal milestone for Corstasis Therapeutics, signifying the FDA’s determination that the application is sufficiently complete to move forward with a comprehensive ...